Finance

Lists
Q3 2026 earnings • released • EPS beat +2.67% • Revenue miss -2.92%
See results
COO:NASDAQ
Cooper Companies Inc
$54.16
+0.46%
(+0.25) 1D
Sep 14, 2:51:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COO...
Open
$54.78
High
$54.99
Low
$53.60
Mkt. cap
10.30B
Avg. vol.
2.76M
Volume
2.83M
P/E ratio
18.48
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.82
Shares outstanding
190.16M
No. of employees
15K
Open
$54.78
High
$54.99
Low
$53.60
Mkt. cap
10.30B
Avg. vol.
2.76M
Volume
2.83M
P/E ratio
18.48
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.82
Shares outstanding
190.16M
No. of employees
15K
News stories
From web sources and news partners
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorMedical device
Websitecoopercos.com
Analyst ratings
Based on 13 analysts giving stock ratings to COO in the past 3 months
Buy
Buy
4
Hold
9
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for COO in the last 3 months.
Highest
Current $54.16
$75.00 (+38.48%)
Average
$65.27 (+20.51%)
Lowest
$58.00 (+7.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Block
Stifel Nicolaus
Buy
Maintained
$70.00
+29.2%
09/13/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$75.00
+38.5%
09/11/2026
Young Li
Jefferies
Buy
Maintained
$70.00
+29.2%
09/10/2026
Steven Lichtman
William Blair
Hold
Downgraded
-
-
09/12/2026
Patrick Wood
UBS
Hold
Reiterated
$66.00
+21.9%
09/10/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$58.00
+7.1%
09/10/2026
Joanne Wuensch
Citi
Hold
Maintained
$60.00
+10.8%
09/11/2026
David Saxon
Needham
Buy
Maintained
$73.00
+34.8%
09/10/2026
Travis Steed
Bank of America Securities
Hold
Downgraded
$65.00
+20%
09/10/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$61.00
+12.6%
09/09/2026
Jason Bednar
Piper Sandler
Hold
Downgraded
$59.00
+8.9%
09/10/2026
Jeff Johnson
Robert W. Baird
Hold
Downgraded
$61.00
+12.6%
09/10/2026
Brett Fishbin
KeyBanc
Hold
Maintained
-
-
09/10/2026
Unknown Analyst
UBS
Hold
Initiated
$75.00
+38.5%
07/28/2026
David Roman
Goldman Sachs
Sell
Maintained
$61.00
+12.6%
05/27/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$82.00
+51.4%
05/22/2026
Matt Miksic
Barclays
Buy
Reiterated
$103.00
+90.2%
03/24/2026
Issie Kirby
Rothschild & Co Redburn
Hold
Downgraded
$85.00
+56.9%
03/04/2026
Last report
Sep 9, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.15 / $1.12
+2.67%beat
Revenue / Est. (USD)
1.07B / 1.10B
-2.92%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
1.06B
1.07B
1.02B
1.08B
Cost of goods sold
368.30M
414.30M
328.90M
346.10M
Cost of revenue
368.30M
414.30M
328.90M
346.10M
Research and development expenses
44.60M
41.40M
44.30M
42.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
421.70M
415.40M
390.20M
676.20M
Operating expense
516.30M
506.60M
482.40M
766.40M
Total operating expenses
884.60M
920.90M
811.30M
1.11B
Operating income
175.70M
144.20M
212.80M
-31.00M
Other non operating income
3.10M
-16.40M
3.10M
4.30M
EBT including unusual items
151.90M
116.80M
192.20M
-48.40M
EBT excluding unusual items
151.90M
101.10M
192.20M
-48.40M
Income tax expense
53.60M
32.20M
61.40M
29.50M
Effective tax rate
35.29%
27.57%
31.95%
-60.95%
Other operating expenses
-
-
-
-
Net income
98.30M
84.60M
130.80M
-77.90M
Net profit margin
9.27%
7.94%
12.77%
-7.20%
Earnings per share
1.10
1.15
1.10
1.21
Interest and investment income
-
-
-
-
Interest expense
-25.40M
-24.40M
-22.40M
-20.90M
Net interest expenses
-25.40M
-24.40M
-22.40M
-20.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.10M
242.60M
308.30M
64.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps